Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Humanised monoclonal IgG4 antibody against tissue factor pathway inhibitor

EU orphan designation number: EU/3/12/1052   
Active ingredient: Humanised monoclonal IgG4 antibody against tissue factor pathway inhibitor
Indication: Treatment of haemophilia A
Sponsor: Novo Nordisk A/S
Novo Allé, 2880 Bagsvaerd, Danmark

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
12/10/2012 Orphan designation EMA/OD/095/12 (2012)7229 of 10/10/2012